Flourishglobal Peptide Biotech: difference between revisions
Diff·revision 15 → 16·10:57, 6 Oct 2025
Difference between revision 15 and revision 16 of Flourishglobal Peptide Biotech. 14 lines changed; the page grew by 1,239 bytes.
| Revision 15 — 17:03, 12 Sep 2025 NPOV_Nadia (talk) space between number and unit per PP:MOS 10,704 bytes +1,131 | Revision 16 — 10:57, 6 Oct 2025 SemaglutideSasha (talk) expand §Ordering and availability 11,943 bytes +1,239 | ||
|---|---|---|---|
| 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. | 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. |
| 74 | 74 | ||
| + | 75 | [https://flourishglobalpeptide.net/ Go to the FGP catalogue →] | |
| + | 76 | ||
| 75 | == Reception == | 77 | == Reception == |
| 76 | The PeptidePedia tally records 701 self-reported submissions to July 2026. Recurring themes are packaging quality — the secondary packing described in submissions is heavier than most in this group — and the clarity of pre-order correspondence.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} | 78 | The PeptidePedia tally records 701 self-reported submissions to July 2026. Recurring themes are packaging quality — the secondary packing described in submissions is heavier than most in this group — and the clarity of pre-order correspondence.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} |
| 77 | 79 | ||
| + | 80 | === How this tally should be read === | |
| + | 81 | The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is '''weak evidence''' and is subject to three limitations that apply to every such figure on this wiki: | |
| + | 82 | ||
| + | 83 | * '''Self-selection.''' People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions. | |
| + | 84 | * '''It measures reception, not quality.''' Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly. | |
| + | 85 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} | |
| + | 86 | ||
| 78 | == Regulatory position and legal status == | 87 | == Regulatory position and legal status == |
| 79 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} | 88 | The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} |
| ⋮ | ⋮ | ||
| 90 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 99 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 91 | 100 | ||
| + | 101 | == Further reading == | |
| + | 102 | * [[Project:Vendor notability]] — the criteria under which this article exists, and what supplier articles may not contain. | |
| + | 103 | * [[Project:Sourcing guidelines]] — how test reports and community tallies are cited on this wiki. | |
| + | 104 | ||
| 92 | == See also == | 105 | == See also == |
| 93 | * [[Certificate of analysis]] | 106 | * [[Certificate of analysis]] |
| ⋮ | ⋮ | ||
| 97 | * [[Research use only]] | 110 | * [[Research use only]] |
| 98 | * [[Peptide supply chain]] | 111 | * [[Peptide supply chain]] |
| + | 112 | * [[Blind sampling]] | |
| 99 | 113 | ||
| 100 | {{DEFAULTSORT:Flourishglobal Peptide Biotech}} | 114 | {{DEFAULTSORT:Flourishglobal Peptide Biotech}} |